Cetera Investment Advisers
SBRA icon

Cetera Investment Advisers’s Sabra Healthcare REIT SBRA Stock Holding History

Cetera Investment Advisers’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
170,701
+6,905
+4% +$137K ﹤0.01% 1929
2026
Q1 		$3.15M Buy
163,796
+10,082
+7% +$199K ﹤0.01% 1853
2025
Q4 		$2.91M Sell
153,714
-3,673
-2% -$68.1K ﹤0.01% 1878
2025
Q3 		$2.93M Buy
157,387
+50,235
+47% +$938K ﹤0.01% 1843
2025
Q2 		$1.98M Buy
107,152
+2,203
+2% +$39.1K ﹤0.01% 1852
2025
Q1 		$1.83M Sell
104,949
-291,132
-74% -$4.91M ﹤0.01% 1813
2024
Q4 		$6.86M Buy
396,081
+25,160
+7% +$459K 0.01% 873
2024
Q3 		$6.9M Sell
370,921
-43,131
-10% -$727K 0.02% 850
2024
Q2 		$6.38M Buy
414,052
+7,377
+2% +$105K 0.01% 872
2024
Q1 		$6.01M Buy
406,675
+103,413
+34% +$1.43M 0.01% 893
2023
Q4 		$4.33M Buy
303,262
+6,908
+2% +$98.1K 0.04% 490
2023
Q3 		$4.13M Buy
296,354
+13,553
+5% +$173K 0.04% 476
2023
Q2 		$3.33M Buy
282,801
+8,334
+3% +$94.9K 0.03% 567
2023
Q1 		$3.16M Buy
274,467
+185,514
+209% +$2.29M 0.03% 549
2022
Q4 		$1.11M Buy
88,953
+6,577
+8% +$83.9K 0.01% 950
2022
Q3 		$1.08M Buy
82,376
+1,504
+2% +$22.2K 0.02% 686
2022
Q2 		$1.13M Buy
80,872
+264
+0.3% +$3.53K 0.02% 747
2022
Q1 		$1.2M Buy
80,608
+919
+1% +$12.6K 0.02% 755
2021
Q4 		$1.08M Buy
79,689
+65,221
+451% +$923K 0.02% 785
2021
Q3 		$213K Buy
14,468
+454
+3% +$7.67K ﹤0.01% 1632
2021
Q2 		$255K Buy
14,014
+1,315
+10% +$23.4K ﹤0.01% 1515
2021
Q1 		$220K Buy
12,699
+594
+5% +$10.4K ﹤0.01% 1420
2020
Q4 		$210K Buy
12,105
+1,972
+19% +$31.5K ﹤0.01% 1428
2020
Q3 		$140K Buy
+10,133
New +$149K 0.01% 613
2020
Q2 		– Sell
-10,040
Closed -$110K – 630
2020
Q1 		$110K Buy
+10,040
New +$185K 0.01% 515

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Cetera Investment Advisers's SBRA Position: Q2 2026 in Review

Cetera Investment Advisers increased its Sabra Healthcare REIT (SBRA) stake by 4.2% in Q2 2026, buying an estimated $137K and bringing the position to 170,701 shares worth $3.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Cetera Investment Advisers first reported a position in SBRA in Q1 2020 and has held it in 25 quarters since. The position peaked at $6.9M in Q3 2024. 465 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Cetera Investment Advisers held 170,701 shares of Sabra Healthcare REIT worth $3.33M as of Q2 2026.
  • Cetera Investment Advisers bought 6,905 Sabra Healthcare REIT shares in Q2 2026, an estimated $137K.
  • Sabra Healthcare REIT made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1929 holding.
  • Cetera Investment Advisers first reported a position in Sabra Healthcare REIT in Q1 2020 and has held it in 25 quarters since.
  • Cetera Investment Advisers's Sabra Healthcare REIT position peaked at $6.9M in Q3 2024.
  • 465 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.